10-K annual report · filed Feb 26, 2025

Altria (MO) FY2024 10-K Annual Report

Short answer

Altria (MO) filed its fiscal 2024 10-K annual report with the SEC on Feb 26, 2025. It reported revenue of $24.0B (−1.9% year over year) and net income of $11.3B.

  • Top risk flagged: Legal risk from IRS agreement on $6.4B ordinary loss relating to JUUL investment tax treatment in October 2024

FY2024 key financial metrics · XBRL

Revenue
$24.0B
−1.9% YoY
Net income
$11.3B
+38.5% YoY
Operating margin
46.8%
−0.4 pp YoY
Gross margin
59.8%
+1.5 pp YoY
EPS (diluted)
$6.54
+43.1% YoY
ROE
-503.3%
−273.6 pp YoY
Operating cash flow
$8.8B
−5.7% YoY

Source: XBRL data from the Altria (MO) FY2024 10-K on SEC EDGAR. USD.

Altria FY2024 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Core business: Leadership in U.S. tobacco industry with strategic focus on smoke-free and innovative nicotine products
  • Emphasis on U.S. smoke-free portfolio: target 35% volume growth from 800M units in 2022, aiming to double net revenues to $5B by 2028
  • New strategic Initiative launched Oct 2024 to modernize operations, targeting $600M cumulative cost savings over five years with $100M-$125M charges
  • Long-term growth includes international expansion in oral tobacco and entry into non-nicotine categories with 5+ products by 2028
  • Reassessment of smoke-free goals due to illicit flavored e-vapor product proliferation and enforcement challenges impacting market clarity

Management Discussion & Analysis

  • Best segment: PM USA (most profitable U.S. cigarette manufacturer); worst segment metrics not disclosed
  • Forward-looking outlook emphasizes transitioning adult smokers to smoke-free products and innovation in less harmful tobacco alternatives

Risk Factors

  • Legal risk from IRS agreement on $6.4B ordinary loss relating to JUUL investment tax treatment in October 2024
  • Operational risk from contingent NJOY payments totaling $250 million impacting cash flows in 2023-2024
  • Financial risk with $0.9 billion accrued postretirement health care costs and $84 million estimated annual payments
  • Market risk as smokeable product shipment volume decline leads to lower revenues and federal excise tax payments
  • Capital expenditure decrease 27.6% to $142 million in 2024 with 2025 forecasted $175-$225 million funded by operating cash

Generated from the filing text; verify against the original. How to read a 10-K

Other Altria annual reports

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.